---
title: "Systematic Literature Review"
description: In this blog we will explore systematic literature review approaches and tools.
author:
  - name: Lethean Scribe
date: "2025-11-02"
categories: [SLR]
image: image.jpeg
---

*Blog post: /2025-11-02-systematic-literature-review*

------------------------------------------------------------------------

## Introduction

A **systematic literature review (SLR)** is a rigorous, reproducible method
that synthesizes evidence using a predefined protocol to minimize bias.<sup><a
  href="#ref13">13</a>, <a href="#ref19">19</a>, <a href="#ref23">23</a></sup>
Begin by clearly defining scope and research questions,<sup><a
  href="#ref9">9</a>, <a href="#ref10">10</a></sup> structuring the review from
broad context to focused themes.<sup><a href="#ref1">1</a>, <a
  href="#ref2">2</a></sup> Unlike an introduction, which previews your study,
an SLR critically synthesizes existing research.<sup><a
  href="#ref4">4</a></sup> Place it early in a thesis to establish
context,<sup><a href="#ref5">5</a></sup> adapting structure (thematic,
chronological, or methodological) by discipline.<sup><a href="#ref6">6</a>, <a
  href="#ref11">11</a></sup> Avoid mere summarization; critically evaluate
sources for quality and contradictions.<sup><a href="#ref7">7</a>, <a
  href="#ref8">8</a>, <a href="#ref20">20</a></sup> Conduct systematic searches
across databases, document strategies, and use reference managers from the
start.<sup><a href="#ref14">14</a>, <a href="#ref15">15</a></sup> Screen in two
stages—title/abstract then full-text—before extracting data with
templates.<sup><a href="#ref3">3</a>, <a href="#ref10">10</a></sup> Synthesize
findings conceptually, identify gaps, and justify future research.<sup><a
  href="#ref16">16</a>, <a href="#ref17">17</a>, <a href="#ref18">18</a></sup>
Variants include bibliometric analysis for mapping impact<sup><a
  href="#ref21">21</a></sup> and integrative reviews for diverse
methodologies.<sup><a href="#ref22">22</a></sup>

Systematic literature reviews have become the gold standard for synthesizing
research evidence across disciplines. Unlike traditional narrative reviews,
systematic reviews follow a rigorous, transparent, and reproducible methodology
that minimizes bias and provides reliable conclusions. This comprehensive guide
walks you through each step of conducting a systematic literature review, from
initial planning to final dissemination.

## What is a Systematic Literature Review?

A systematic literature review is a methodical approach to identifying,
evaluating, and synthesizing all relevant research on a specific question or
topic. It differs from traditional literature reviews in its explicit
methodology, comprehensive search strategy, and transparent reporting of how
studies were selected and appraised.

### Systematic vs. Traditional Literature Review

| Feature | Traditional Literature Review | Systematic Literature Review |
|---------|------------------------------|------------------------------|
| **Research Question** | Broad, general | Focused, specific (e.g., PICO) |
| **Search Strategy** | Not specified, potentially biased | Comprehensive, documented, reproducible |
| **Study Selection** | Not specified, subjective | Explicit criteria, multiple reviewers |
| **Quality Assessment** | Variable or absent | Standardized, rigorous tools |
| **Data Synthesis** | Narrative, subjective | Systematic (narrative or meta-analysis) |
| **Bias Minimization** | Limited | Multiple safeguards |
| **Reproducibility** | Low | High |
| **Time Required** | Weeks to months | 6-18 months |

## Overall Systematic Review Workflow

```
┌─────────────────────────────────────────────────────────────┐
│                    PLANNING PHASE                           │
│  ┌──────────────┐    ┌──────────────┐    ┌──────────────┐   │
│  │  Define      │───▶│  Develop     │───▶│  Establish   │   │
│  │  Research    │    │  Protocol    │    │  Eligibility │   │
│  │  Question    │    │              │    │  Criteria    │   │
│  └──────────────┘    └──────────────┘    └──────────────┘   │
│                            │                                │
│                            ▼                                │
│                   ┌──────────────┐                          │
│                   │  Register    │                          │
│                   │  Protocol    │                          │
│                   └──────────────┘                          │
└─────────────────────────────────────────────────────────────┘
                            │
                            ▼
┌─────────────────────────────────────────────────────────────┐
│                  SEARCH & SELECTION PHASE                   │
│  ┌──────────────┐    ┌──────────────┐    ┌──────────────┐   │
│  │  Design      │───▶│  Execute     │───▶│  Screen      │   │
│  │  Search      │    │  Searches    │    │  Titles &    │   │
│  │  Strategy    │    │              │    │  Abstracts   │   │
│  └──────────────┘    └──────────────┘    └──────────────┘   │
│                                                 │           │
│                                                 ▼           │
│                                        ┌──────────────┐     │
│                                        │  Full-Text   │     │
│                                        │  Review      │     │
│                                        └──────────────┘     │
└─────────────────────────────────────────────────────────────┘
                            │
                            ▼
┌─────────────────────────────────────────────────────────────┐
│                  DATA COLLECTION PHASE                      │
│  ┌──────────────┐    ┌──────────────┐    ┌──────────────┐   │
│  │  Extract     │───▶│  Assess      │───▶│  Assess      │   │
│  │  Data        │    │  Study       │    │  Evidence    │   │
│  │              │    │  Quality     │    │  Certainty   │   │
│  └──────────────┘    └──────────────┘    └──────────────┘   │
└─────────────────────────────────────────────────────────────┘
                            │
                            ▼
┌─────────────────────────────────────────────────────────────┐
│                  SYNTHESIS & REPORTING PHASE                │
│  ┌──────────────┐    ┌──────────────┐    ┌──────────────┐   │
│  │  Synthesize  │───▶│  Write       │───▶│  Disseminate │   │
│  │  Data        │    │  Review      │    │  & Update    │   │
│  │              │    │              │    │              │   │
│  └──────────────┘    └──────────────┘    └──────────────┘   │
└─────────────────────────────────────────────────────────────┘
```

## Step 1: Defining the Research Question

The foundation of any systematic review is a well-formulated research question.
A poorly defined question leads to unfocused searches, irrelevant studies, and
ultimately, inconclusive results.

### Research Question Frameworks

| Framework | Best For | Components | Example |
|-----------|----------|------------|---------|
| **PICO** | Quantitative studies, interventions | Population, Intervention, Comparison, Outcome | In adults with T2DM (P), does Mediterranean diet (I) vs low-fat diet (C) improve HbA1c (O)? |
| **PEO** | Observational studies | Population, Exposure, Outcome | In adolescents (P), does social media use (E) affect mental health (O)? |
| **PICo** | Qualitative studies | Population, Interest, Context | What are experiences of nurses (P) regarding end-of-life care (I) in ICU settings (Co)? |
| **SPIDER** | Qualitative/mixed methods | Sample, Phenomenon, Design, Evaluation, Research type | What are patients' (S) experiences of telehealth (PI) explored through interviews (D/R)? |
| **SPICE** | Social sciences | Setting, Perspective, Intervention, Comparison, Evaluation | In schools (S), how do teachers (P) view anti-bullying programs (I) vs standard policies (C)? |

### PICO Framework Detailed

```
┌─────────────────────────────────────────────────────────────┐
│                    PICO FRAMEWORK                           │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  P - POPULATION                                             │
│  └─▶ Who are you studying?                                  │
│      • Demographics (age, gender, ethnicity)                │
│      • Condition/disease                                    │
│      • Setting (hospital, community, school)                │
│      • Severity/stage                                       │
│                                                             │
│  I - INTERVENTION                                           │
│  └─▶ What is being tested/applied?                          │
│      • Treatment/therapy                                    │
│      • Diagnostic test                                      │
│      • Exposure/risk factor                                 │
│      • Prognostic factor                                    │
│                                                             │
│  C - COMPARISON                                             │
│  └─▶ What is it compared to?                                │
│      • Placebo                                              │
│      • Standard care                                        │
│      • Alternative intervention                             │
│      • No intervention                                      │
│                                                             │
│  O - OUTCOME                                                │
│  └─▶ What are you measuring?                                │
│      • Primary outcomes                                     │
│      • Secondary outcomes                                   │
│      • Time points                                          │
│      • Measurement method                                   │
│                                                             │
└─────────────────────────────────────────────────────────────┘
```

## Step 2: Developing the Review Protocol

Before beginning your search, create a detailed protocol that outlines your
entire methodology. This protocol serves as your roadmap and helps maintain
consistency throughout the review process.

### Protocol Components Checklist

| Section | Key Elements | Status |
|---------|-------------|---------|
| **Title** | • Clear identification as systematic review<br>• Topic and population specified | ☐ |
| **Background** | • Rationale for review<br>• Summary of existing evidence<br>• Knowledge gaps | ☐ |
| **Objectives** | • Primary objectives<br>• Secondary objectives<br>• Research questions | ☐ |
| **Methods: Eligibility** | • PICO/framework criteria<br>• Study designs included<br>• Language restrictions<br>• Publication dates | ☐ |
| **Methods: Search** | • Databases to search<br>• Search terms<br>• Gray literature sources<br>• Citation searching plan | ☐ |
| **Methods: Selection** | • Screening process<br>• Number of reviewers<br>• Disagreement resolution | ☐ |
| **Methods: Data Collection** | • Extraction form design<br>• Variables to extract<br>• Pilot testing plan | ☐ |
| **Methods: Quality Assessment** | • Assessment tools<br>• Domains to evaluate<br>• Independent assessment plan | ☐ |
| **Methods: Synthesis** | • Narrative or meta-analysis<br>• Subgroup analyses planned<br>• Heterogeneity assessment | ☐ |
| **Timeline** | • Estimated completion dates<br>• Milestones | ☐ |
| **Team** | • Reviewers and roles<br>• Expertise areas | ☐ |

### Protocol Registration Options

| Registry | Suitable For | Website | Cost |
|----------|--------------|---------|------|
| **PROSPERO** | Health-related reviews | www.crd.york.ac.uk/prospero | Free |
| **Open Science Framework** | Any discipline | osf.io | Free |
| **Cochrane Library** | Cochrane reviews only | www.cochranelibrary.com | Free |
| **Campbell Collaboration** | Social sciences | www.campbellcollaboration.org | Free |

## Step 3: Establishing Inclusion and Exclusion Criteria

Clear eligibility criteria ensure consistency in study selection and help other
researchers understand the scope of your review.

### Sample Eligibility Criteria Table

| Criterion | Inclusion | Exclusion | Rationale |
|-----------|-----------|-----------|-----------|
| **Study Design** | Randomized controlled trials (RCTs), quasi-experimental studies | Case reports, editorials, opinion pieces | Need rigorous evaluation of causality |
| **Population** | Adults aged 18-65 with diagnosed type 2 diabetes | Type 1 diabetes, gestational diabetes, prediabetes | Focus on specific diabetic population |
| **Intervention** | Dietary interventions lasting ≥12 weeks | Pharmaceutical interventions, interventions <12 weeks | Sufficient duration to see metabolic effects |
| **Comparison** | Any comparison diet or usual care | No comparison group | Need comparative data |
| **Outcomes** | HbA1c, fasting glucose, lipid profiles | Quality of life only (without clinical markers) | Primary interest in metabolic outcomes |
| **Language** | English, Spanish, French | All other languages | Team language capabilities |
| **Publication Date** | January 2010 - present | Before 2010 | Recent dietary guidelines changed in 2010 |
| **Publication Type** | Peer-reviewed journals | Conference abstracts without full publication | Need complete methodology and results |

## Step 4: Designing the Search Strategy

A comprehensive search strategy is crucial for identifying all relevant studies
and minimizing publication bias.

### Database Selection by Discipline

| Discipline | Primary Databases | Supplementary Databases |
|------------|-------------------|------------------------|
| **Medicine/Health** | PubMed/MEDLINE, Embase, Cochrane Library | CINAHL, PsycINFO, Web of Science |
| **Psychology** | PsycINFO, PubMed, Scopus | PsycARTICLES, Web of Science |
| **Education** | ERIC, Education Source | British Education Index, Web of Science |
| **Social Sciences** | Sociological Abstracts, Social Sciences Citation Index | JSTOR, ProQuest |
| **Engineering** | IEEE Xplore, Engineering Village | ACM Digital Library, Scopus |
| **Business** | Business Source Complete, ABI/INFORM | EconLit, Web of Science |
| **Environmental** | Web of Science, Scopus | GeoRef, Environmental Science Database |

### Search Strategy Development Process

```
┌─────────────────────────────────────────────────────────────┐
│              SEARCH STRATEGY DEVELOPMENT                    │
└─────────────────────────────────────────────────────────────┘
    │
    ├─▶ STEP 1: Identify Key Concepts from PICO
    │   • Break down each component
    │   • List main concepts
    │
    ├─▶ STEP 2: Generate Synonyms and Related Terms
    │   • Use thesauri and dictionaries
    │   • Consider spelling variations
    │   • Include acronyms and abbreviations
    │
    ├─▶ STEP 3: Identify Database Subject Headings
    │   • MeSH terms (PubMed)
    │   • Emtree terms (Embase)
    │   • Check each database's controlled vocabulary
    │
    ├─▶ STEP 4: Build Search Strings
    │   • Combine synonyms with OR
    │   • Combine concepts with AND
    │   • Use truncation (*) and wildcards (?)
    │   • Apply proximity operators (NEAR, ADJ)
    │
    ├─▶ STEP 5: Add Filters
    │   • Date range
    │   • Language
    │   • Publication type
    │   • Study design (if possible)
    │
    ├─▶ STEP 6: Pilot Test
    │   • Run in one database
    │   • Check sample of results
    │   • Verify known studies are captured
    │
    ├─▶ STEP 7: Refine
    │   • Adjust sensitivity/specificity
    │   • Add missing terms
    │   • Remove ineffective terms
    │
    └─▶ STEP 8: Adapt for Each Database
        • Modify syntax as needed
        • Translate subject headings
        • Document all variations
```

### Sample Search Strategy

**Example Topic**: Mediterranean diet and glycemic control in type 2 diabetes

| Concept | Search Terms | Combined With |
|---------|--------------|---------------|
| **Population** | ("diabetes mellitus, type 2"[MeSH] OR "type 2 diabetes" OR "T2DM" OR "adult onset diabetes" OR "non-insulin dependent diabetes" OR "NIDDM") | AND |
| **Intervention** | ("diet, mediterranean"[MeSH] OR "mediterranean diet*" OR "Mediterranean-style diet*" OR "MedDiet" OR "med diet") | AND |
| **Outcome** | ("glycated hemoglobin"[MeSH] OR "HbA1c" OR "hemoglobin A1c" OR "glycemic control" OR "blood glucose" OR "fasting glucose" OR "glucose control") | — |
| **Filters** | English language, January 2010-present, Humans | — |

**Combined Search String**:
```
("diabetes mellitus, type 2"[MeSH] OR "type 2 diabetes" OR "T2DM" OR 
"adult onset diabetes" OR "non-insulin dependent diabetes" OR "NIDDM")
AND
("diet, mediterranean"[MeSH] OR "mediterranean diet*" OR 
"Mediterranean-style diet*" OR "MedDiet" OR "med diet")
AND
("glycated hemoglobin"[MeSH] OR "HbA1c" OR "hemoglobin A1c" OR 
"glycemic control" OR "blood glucose" OR "fasting glucose" OR 
"glucose control")
Filters: English, 2010-present, Humans
```

### Search Documentation Template

| Database | Platform | Date | Search # | Search Terms | Limiters | Results |
|----------|----------|------|----------|--------------|----------|---------|
| PubMed | NLM | 2025-03-15 | #1 | "diabetes mellitus, type 2"[MeSH] | None | 156,823 |
| PubMed | NLM | 2025-03-15 | #2 | "type 2 diabetes" OR T2DM OR NIDDM | None | 203,456 |
| PubMed | NLM | 2025-03-15 | #3 | #1 OR #2 | None | 245,789 |
| PubMed | NLM | 2025-03-15 | #4 | "diet, mediterranean"[MeSH] OR "mediterranean diet*" | None | 3,456 |
| PubMed | NLM | 2025-03-15 | #5 | #3 AND #4 | None | 234 |
| PubMed | NLM | 2025-03-15 | #6 | #5 AND ("HbA1c" OR "glycemic control"...) | English, 2010-present | 87 |

## Step 5: Conducting the Search

Execute your search strategy systematically across all selected databases.

### Search Execution Timeline

```
Week 1-2: Database Searches
│
├─ Day 1-2: Primary databases (PubMed, Embase, Cochrane)
├─ Day 3-4: Discipline-specific databases
├─ Day 5-6: Gray literature sources
└─ Day 7-10: Citation searching and hand searching

Week 3: De-duplication and Organization
│
├─ Import all results to reference manager
├─ Run automated duplicate detection
├─ Manual duplicate check
└─ Create screening database

Week 4: Preparation for Screening
│
├─ Set up screening software (Covidence, DistillerSR, Rayyan)
├─ Train additional reviewers
├─ Conduct pilot screening on 50-100 records
└─ Finalize screening forms and processes
```

### Search Results Summary Table

| Source | Date Searched | Results Retrieved | After De-duplication |
|--------|---------------|-------------------|---------------------|
| PubMed | 2025-03-15 | 1,247 | — |
| Embase | 2025-03-15 | 1,834 | — |
| Cochrane Library | 2025-03-15 | 156 | — |
| CINAHL | 2025-03-16 | 423 | — |
| Web of Science | 2025-03-16 | 967 | — |
| Citation searching | 2025-03-17 | 78 | — |
| Gray literature | 2025-03-18 | 34 | — |
| Hand searching | 2025-03-18 | 12 | — |
| **Total** | — | **4,751** | **3,842** |

## Step 6: Screening and Study Selection

Study selection typically occurs in two stages: title/abstract screening followed by full-text review.

### PRISMA 2020 Flow Diagram

```
┌─────────────────────────────────────────────────────────────┐
│                     IDENTIFICATION                          │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Records identified from:              Records identified   │
│  Databases (n = 4,739)                 from other sources:  │
│  • PubMed (n = 1,247)                  • Citation (n = 78)  │
│  • Embase (n = 1,834)                  • Gray lit (n = 34)  │
│  • Cochrane (n = 156)                  • Hand (n = 12)      │
│  • CINAHL (n = 423)                                         │
│  • Web of Science (n = 967)            (n = 124)            │
│  • Registers (n = 112)                                      │
│                                                             │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│  Records removed before screening:                          │
│  • Duplicate records (n = 909)                              │
│  • Records marked ineligible by automation tools (n = 112)  │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│                      SCREENING                              │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Records screened                    Records excluded       │
│  (n = 3,842)                        (n = 3,567)             │
│                                                             │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│  Reports sought for retrieval        Reports not retrieved  │
│  (n = 275)                          (n = 8)                 │
│                                                             │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│  Reports assessed for eligibility  Reports excluded:        │
│  (n = 267)                         (n = 224)                │
│                                    • Wrong population (87)  │
│                                    • Wrong intervention (56)│
│                                    • Wrong outcome (42)     │
│                                    • Wrong study design (29)│
│                                    • Wrong publication (10) │
└────────────────────┬────────────────────────────────────────┘
                     │
                     ▼
┌─────────────────────────────────────────────────────────────┐
│                      INCLUDED                               │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│  Studies included in review                                 │
│  (n = 43)                                                   │
│                                                             │
│  Reports of included studies                                │
│  (n = 43)                                                   │
│                                                             │
└─────────────────────────────────────────────────────────────┘
```

### Screening Process Workflow

| Stage | Process | Reviewers | Tool | Output |
|-------|---------|-----------|------|--------|
| **Title/Abstract** | Quick screening against broad eligibility | 2 independent | Covidence/Rayyan | Include/Exclude/Uncertain |
| **Conflict Resolution** | Discuss disagreements | 2 + 1 arbiter if needed | Discussion meeting | Consensus decision |
| **Full-Text** | Detailed assessment against all criteria | 2 independent | Covidence/Manual | Include/Exclude with reason |
| **Final Selection** | Resolve conflicts, finalize list | 2 + 1 arbiter | Discussion meeting | Final included studies |

### Inter-Rater Reliability

| Kappa Value | Interpretation | Action Needed |
|-------------|----------------|---------------|
| < 0.20 | Poor agreement | Review criteria, retrain reviewers, discuss discrepancies |
| 0.21 - 0.40 | Fair agreement | Clarify criteria, discuss challenging cases |
| 0.41 - 0.60 | Moderate agreement | Minor refinements to process |
| 0.61 - 0.80 | Good agreement | Continue with current process |
| 0.81 - 1.00 | Excellent agreement | Process working well |

## Step 7: Data Extraction

Systematic data extraction ensures you collect consistent information from each
study and reduces errors.

### Data Extraction Form Template

| Category | Data Elements | Details |
|----------|---------------|---------|
| **Study Identification** | • First author<br>• Publication year<br>• Title<br>• Journal<br>• DOI<br>• Country | Basic bibliographic info |
| **Study Characteristics** | • Study design<br>• Setting (hospital, community, etc.)<br>• Study duration<br>• Follow-up period<br>• Funding source | Methodological details |
| **Population** | • Sample size (total, per group)<br>• Age (mean, range)<br>• Sex distribution<br>• Inclusion criteria<br>• Exclusion criteria<br>• Baseline characteristics | Participant details |
| **Intervention** | • Intervention description<br>• Duration<br>• Intensity/frequency<br>• Delivery method<br>• Provider training<br>• Adherence measurement | Treatment details |
| **Comparison** | • Control/comparison description<br>• Duration<br>• Co-interventions | Control group details |
| **Outcomes** | • Primary outcomes<br>• Secondary outcomes<br>• Measurement tools<br>• Time points<br>• Results (means, SDs, effect sizes)<br>• Statistical significance | Results data |
| **Quality Indicators** | • Randomization method<br>• Allocation concealment<br>• Blinding<br>• Attrition rate<br>• ITT analysis<br>• Conflicts of interest | Risk of bias data |

### Data Extraction Process

```
┌────────────────────────────────────────────────────────┐
│            DATA EXTRACTION WORKFLOW                    │
└────────────────────────────────────────────────────────┘

STEP 1: Design Extraction Form
│
├─ List all data elements needed
├─ Create standardized form/spreadsheet
├─ Include dropdown menus for categorical data
└─ Add instructions and coding guidelines

STEP 2: Pilot Test (5-10 studies)
│
├─ Two reviewers extract independently
├─ Compare results
├─ Calculate agreement
├─ Identify ambiguities
└─ Revise form as needed

STEP 3: Train Reviewers
│
├─ Review form instructions
├─ Practice on sample studies
├─ Discuss challenging scenarios
└─ Establish decision rules

STEP 4: Independent Extraction
│
├─ Each reviewer extracts data independently
├─ Do not discuss until both complete
├─ Use same form/software
└─ Flag uncertainties

STEP 5: Compare and Reconcile
│
├─ Compare extractions systematically
├─ Calculate agreement statistics
├─ Discuss discrepancies
├─ Reach consensus
└─ Document decisions

STEP 6: Contact Authors (if needed)
│
├─ Draft polite, specific request
├─ Allow 2-4 weeks for response
├─ Send one reminder if no response
├─ Document all correspondence
└─ Note missing data in review

STEP 7: Create Data Summary Tables
│
├─ Table of study characteristics
├─ Table of results by outcome
├─ Risk of bias summary
└─ Additional tables as needed
```

## Step 8: Assessing Study Quality and Risk of Bias

Quality assessment evaluates the methodological rigor of included studies and
helps interpret findings.

### Risk of Bias Tools by Study Design

| Study Design | Recommended Tool | Key Domains |
|--------------|------------------|-------------|
| **Randomized Controlled Trials** | Cochrane RoB 2 | Randomization, deviations from intended interventions, missing outcome data, outcome measurement, selective reporting |
| **Non-randomized Studies** | ROBINS-I | Confounding, participant selection, intervention classification, deviations, missing data, outcome measurement, selective reporting |
| **Observational Studies** | Newcastle-Ottawa Scale | Selection, comparability, outcome/exposure |
| **Diagnostic Accuracy** | QUADAS-2 | Patient selection, index test, reference standard, flow and timing |
| **Qualitative Studies** | CASP Qualitative Checklist | Research design, data collection, trustworthiness, analysis, findings |
| **Mixed Methods** | MMAT | Appropriate rationale, integration of methods, interpretation of results, limitations |
| **Systematic Reviews** | AMSTAR 2 | Protocol registration, search comprehensiveness, study selection, quality assessment, synthesis methods |

### Cochrane Risk of Bias 2 (RoB 2) Domains

```
┌─────────────────────────────────────────────────────────────┐
│              COCHRANE ROB 2 ASSESSMENT                      │
└─────────────────────────────────────────────────────────────┘

Domain 1: Bias arising from randomization process
├─ Was allocation sequence random?
├─ Was allocation sequence concealed?
└─ Were baseline differences suggesting a problem?
   → Low risk / Some concerns / High risk

Domain 2: Bias due to deviations from intended interventions
├─ Were participants/personnel aware of intervention?
├─ Were there deviations from intended intervention?
├─ Were deviations balanced between groups?
└─ Was analysis appropriate?
   → Low risk / Some concerns / High risk

Domain 3: Bias due to missing outcome data
├─ Were data available for all/nearly all participants?
├─ Is there evidence data missing depended on its true value?
└─ Could missingness in outcome depend on its true value?
   → Low risk / Some concerns / High risk

Domain 4: Bias in measurement of outcome
├─ Was measurement method appropriate?
├─ Did measurement differ between groups?
└─ Were outcome assessors aware of intervention?
   → Low risk / Some concerns / High risk

Domain 5: Bias in selection of reported result
├─ Were outcomes analyzed according to pre-specified plan?
├─ Were multiple analyses performed?
└─ Was reported result likely selected from multiple analyses?
   → Low risk / Some concerns / High risk

OVERALL RISK OF BIAS
└─ Low risk: Low across all domains
   Some concerns: Some concerns in ≥1 domain
   High risk: High in ≥1 domain OR concerns in multiple domains
```

### Risk of Bias Summary Table

| Study | Random Sequence | Allocation Concealment | Blinding Participants | Blinding Assessors | Incomplete Data | Selective Reporting | Overall |
|-------|----------------|----------------------|---------------------|-------------------|----------------|-------------------|---------|
| Smith 2020 | ✓ Low | ✓ Low | ✓ Low | ✓ Low | ⚠ Some concerns | ✓ Low | ⚠ Some concerns |
| Jones 2021 | ✓ Low | ⚠ Some concerns | ✗ High | ✓ Low | ✓ Low | ✓ Low | ✗ High |
| Brown 2022 | ✓ Low | ✓ Low | ✓ Low | ✓ Low | ✓ Low | ✓ Low | ✓ Low |
| Davis 2023 | ⚠ Some concerns | ✓ Low | ✗ High | ⚠ Some concerns | ✓ Low | ✓ Low | ✗ High |

**Legend**: ✓ = Low risk, ⚠ = Some concerns, ✗ = High risk

### Risk of Bias Graph

```
Percentage of studies with each risk of bias judgment

Randomization             ████████████████████ 85% Low
                          ███ 15% Some concerns

Allocation Concealment    ██████████████ 70% Low
                          ████ 20% Some concerns
                          ██ 10% High

Blinding (participants)   ████████ 40% Low
                          ████ 20% Some concerns
                          ████████ 40% High

Blinding (assessors)      ████████████ 60% Low
                          ██████ 30% Some concerns
                          ██ 10% High

Incomplete Outcome Data   ████████████████ 80% Low
                          ████ 20% Some concerns

Selective Reporting       ██████████████████ 90% Low
                          ██ 10% Some concerns

Overall Risk of Bias      ██████████ 50% Low
                          ██████ 30% Some concerns
                          ████ 20% High
```

## Step 9: Data Synthesis

Synthesis integrates findings across studies to answer your research question.

### Choosing Synthesis Method

| Factor | Narrative Synthesis | Meta-Analysis |
|--------|-------------------|---------------|
| **Study Homogeneity** | Studies too diverse | Studies sufficiently similar |
| **Outcome Measures** | Different measurement tools/scales | Same or convertible measures |
| **Statistical Data** | Incomplete or varied reporting | Complete statistical data available |
| **Study Designs** | Multiple different designs | Same design (typically RCTs) |
| **Populations** | Highly variable | Comparable populations |
| **Interventions** | Diverse interventions | Similar interventions |
| **When to Use** | High heterogeneity, limited data | Low-moderate heterogeneity, adequate data |

### Meta-Analysis Statistical Concepts

| Concept | Description | Interpretation |
|---------|-------------|----------------|
| **Effect Size** | Standardized measure of intervention effect | Cohen's d: 0.2=small, 0.5=medium, 0.8=large |
| **Confidence Interval** | Range likely to contain true effect | If excludes null value, effect is significant |
| **Heterogeneity (I²)** | Percentage of variability due to heterogeneity not chance | 0-40%: Low, 30-60%: Moderate, 50-90%: Substantial, 75-100%: Considerable |
| **Fixed-Effect Model** | Assumes one true effect size | Use when I² <40% |
| **Random-Effects Model** | Assumes distribution of true effects | Use when I² >40% |
| **Forest Plot** | Visual display of study results and pooled estimate | Shows effect sizes with confidence intervals |
| **Funnel Plot** | Scatter plot for publication bias detection | Asymmetry suggests bias |

### Sample Forest Plot Structure

```
┌─────────────────────────────────────────────────────────────────────┐
│                    FOREST PLOT EXAMPLE                              │
│  Effect of Mediterranean Diet on HbA1c (%) vs Control               │
├─────────────────────────────────────────────────────────────────────┤
│                                                                     │
│ Study                     Mean Difference [95% CI]        Weight %  │
│                          -2.0  -1.0   0   1.0   2.0                 │
│                           |     |     |    |     |                  │
│ Smith 2020                ●─────|─────|    |     |        12.5%     │
│   MD: -0.85 [-1.2, -0.5]  |     |     |    |     |                  │
│                           |     |     |    |     |                  │
│ Jones 2021                |    ●──────|────|     |        15.3%     │
│   MD: -0.62 [-0.9, -0.3]  |     |     |    |     |                  │
│                           |     |     |    |     |                  │
│ Brown 2022                |     ●─────|────|     |        18.2%     │
│   MD: -0.45 [-0.7, -0.2]  |     |     |    |     |                  │
│                           |     |     |    |     |                  │
│ Davis 2023                |     |    ●─────|─────|        14.7%     │
│   MD: -0.35 [-0.6, -0.1]  |     |     |    |     |                  │
│                           |     |     |    |     |                  │
│ Wilson 2024               |     |   ●──────|─────|        13.8%     │
│   MD: -0.28 [-0.5, -0.05]|      |     |    |     |                  │
│                           |     |     |    |     |                  │
│ Taylor 2024               |     |  ●───────|─────|        11.2%     │
│   MD: -0.15 [-0.4, 0.1]   |     |     |    |     |                  │
│                           |     |     |    |     |                  │
│ Anderson 2024             |     |    ●─────|─────|        14.3%     │
│   MD: -0.22 [-0.5, 0.05]  |     |     |    |     |                  │
│                           |     |     |    |     |                  │
│ ═══════════════════════════════════════════════════════════════     │
│ Overall (Random)          |     ◆────|─────|     |        100%      │
│   MD: -0.42 [-0.61, -0.23]|     |    |     |     |                  │
│   I² = 68%, p < 0.001     |     |    |     |     |                  │
│                           |     |    |     |     |                  │
│                       Favours   |   Favours                         │
│                       Mediterranean  Control                        │
│                                                                     │
│ Heterogeneity: I² = 68% (substantial), χ² = 21.8, p < 0.001         │
│ Test for overall effect: Z = 4.32 (p < 0.0001)                      │
└─────────────────────────────────────────────────────────────────────┘
```

### Heterogeneity Assessment

| Statistical Test | What It Measures | Interpretation |
|-----------------|------------------|----------------|
| **Chi-squared (χ²) test** | Statistical significance of heterogeneity | p < 0.10 suggests significant heterogeneity |
| **I² statistic** | Percentage of total variation due to heterogeneity | 0-40%: Might not be important<br>30-60%: Moderate<br>50-90%: Substantial<br>75-100%: Considerable |
| **Tau² (τ²)** | Variance of true effect sizes | No universal interpretation; compare across subgroups |
| **Prediction interval** | Range of true effects in similar future studies | Wider than CI; shows clinical applicability |

### Subgroup Analysis Plan

| Variable | Subgroups | Rationale | Minimum Studies per Subgroup |
|----------|-----------|-----------|------------------------------|
| **Age** | <50 years vs ≥50 years | Metabolic differences by age | 3 |
| **Baseline HbA1c** | <8% vs ≥8% | Disease severity may affect response | 3 |
| **Intervention Duration** | 12-24 weeks vs >24 weeks | Longer duration may show greater effects | 3 |
| **Study Quality** | Low risk vs high risk of bias | Quality may impact effect estimates | 3 |
| **Geographic Region** | North America vs Europe vs Asia | Cultural dietary differences | 3 |
| **Adherence Level** | High (>80%) vs Low (<80%) | Adherence affects outcomes | 3 |

### Publication Bias Assessment

```
┌─────────────────────────────────────────────────────────────┐
│                    FUNNEL PLOT                              │
│         Standard Error (SE) vs Effect Size                  │
├─────────────────────────────────────────────────────────────┤
│                                                             │
│   0.0 ┐                      ●                              │
│       │                    ●   ●                            │
│   0.1 │                  ●   ●   ●                          │
│       │                ●   ●   ●   ●                        │
│   0.2 │              ●   ●   ●   ●   ●                      │
│ S     │            ●   ●   ●   ●   ●   ●                    │
│ E 0.3 │          ●   ●   ●   ● ◆ ●   ●   ●                  │
│       │        ●   ●   ●   ●   ●   ●   ●   ●                │
│   0.4 │      ●   ●   ●   ●   ●   ●   ●   ●   ●              │
│       │    ●   ●   ●   ●   ●   ●   ●   ●   ●   ●            │
│   0.5 └──┼─────┼─────┼─────┼─────┼─────┼─────┼─────┼──      │
│         -2.0  -1.5  -1.0  -0.5   0   0.5   1.0   1.5   2.0  │
│                      Mean Difference                        │
│                                                             │
│  ◆ = Pooled Effect Estimate                                 │
│  Symmetrical funnel = Low publication bias                  │
│  Asymmetry suggests missing studies on one side             │
└─────────────────────────────────────────────────────────────┘
```

**Publication Bias Tests**:

| Test | Result | Interpretation |
|------|--------|----------------|
| **Egger's Test** | p = 0.03 | Significant asymmetry detected |
| **Begg's Test** | p = 0.08 | Borderline significance |
| **Trim and Fill** | 5 studies imputed | Adjusted MD: -0.38 [-0.55, -0.21] |
| **Fail-safe N** | 124 studies | 124 null studies needed to nullify effect |

## Step 10: Assessing Certainty of Evidence

The GRADE (Grading of Recommendations Assessment, Development and Evaluation) approach provides a structured framework for rating evidence certainty.

### GRADE Assessment Process

```
┌─────────────────────────────────────────────────────────────┐
│              GRADE ASSESSMENT WORKFLOW                      │
└─────────────────────────────────────────────────────────────┘

STARTING POINT
├─ Randomized Controlled Trials → HIGH certainty
└─ Observational Studies → LOW certainty

↓ DOWNGRADE FOR:

1. Risk of Bias (-1 or -2)
   └─ Study limitations affecting confidence in results

2. Inconsistency (-1 or -2)
   └─ Unexplained heterogeneity or variability in results

3. Indirectness (-1 or -2)
   └─ Differences in population, intervention, or outcomes

4. Imprecision (-1 or -2)
   └─ Wide confidence intervals, small sample size

5. Publication Bias (-1)
   └─ Strong evidence of missing studies

↑ UPGRADE FOR (observational studies only):

1. Large Effect (+1 or +2)
   └─ RR >2 or <0.5 (no confounders)

2. Dose-Response Gradient (+1)
   └─ Clear gradient supports causality

3. All Plausible Confounding Would Reduce Effect (+1)
   └─ Strengthens confidence in findings

FINAL CERTAINTY RATING
├─ High: Very confident in effect estimate
├─ Moderate: Moderately confident; true effect likely close
├─ Low: Limited confidence; true effect may differ substantially
└─ Very Low: Very little confidence; true effect likely differs
```

### GRADE Evidence Profile Example

| Outcome | Studies (Participants) | Risk of Bias | Inconsistency | Indirectness | Imprecision | Publication Bias | Effect Size | Certainty | Importance |
|---------|------------------------|--------------|---------------|--------------|-------------|------------------|-------------|-----------|------------|
| **HbA1c reduction at 6 months** | 7 RCTs (n=843) | Serious (-1) | Not serious | Not serious | Not serious | Suspected (-1) | MD -0.42% [-0.61, -0.23] | ⊕⊕○○ LOW | Critical |
| **Fasting glucose** | 5 RCTs (n=612) | Serious (-1) | Serious (-1) | Not serious | Not serious | Not detected | MD -12.5 mg/dL [-18.3, -6.7] | ⊕⊕○○ LOW | Critical |
| **Total cholesterol** | 6 RCTs (n=734) | Not serious | Serious (-1) | Not serious | Serious (-1) | Not detected | MD -8.2 mg/dL [-15.1, -1.3] | ⊕⊕○○ LOW | Important |
| **Adverse events** | 4 RCTs (n=523) | Serious (-1) | Not serious | Not serious | Very serious (-2) | Not detected | RR 1.12 [0.68, 1.85] | ⊕○○○ VERY LOW | Important |

**GRADE Certainty Legend**: 
- ⊕⊕⊕⊕ HIGH
- ⊕⊕⊕○ MODERATE  
- ⊕⊕○○ LOW
- ⊕○○○ VERY LOW

## Step 11: Writing the Review

Structure your systematic review following reporting guidelines like PRISMA.

### PRISMA 2020 Checklist

| Section | Item # | Checklist Item | Reported? | Page # |
|---------|--------|----------------|-----------|---------|
| **TITLE** | | | | |
| Title | 1 | Identify report as systematic review | ☐ | |
| **ABSTRACT** | | | | |
| Abstract | 2 | Structured summary (background, objectives, methods, results, conclusions) | ☐ | |
| **INTRODUCTION** | | | | |
| Rationale | 3 | Describe rationale in context of existing knowledge | ☐ | |
| Objectives | 4 | Provide explicit statement of objectives/questions (PICO) | ☐ | |
| **METHODS** | | | | |
| Eligibility criteria | 5 | Specify inclusion/exclusion criteria with rationale | ☐ | |
| Information sources | 6 | Specify all databases, registers, websites, date last searched | ☐ | |
| Search strategy | 7 | Present full search strategy for ≥1 database | ☐ | |
| Selection process | 8 | Specify process for selecting studies (screening, eligibility) | ☐ | |
| Data collection | 9 | Specify methods for data extraction and any confirmation processes | ☐ | |
| Data items | 10a | List and define all outcomes, variables collected | ☐ | |
| | 10b | Specify assumptions and simplifications made | ☐ | |
| Study risk of bias | 11 | Specify methods for assessing risk of bias | ☐ | |
| Effect measures | 12 | Specify effect measures used (RR, MD, etc.) | ☐ | |
| Synthesis methods | 13a | Describe processes for deciding which studies eligible for meta-analysis | ☐ | |
| | 13b | Describe methods for tabular/visual display of results | ☐ | |
| | 13c | Describe methods for synthesizing results (statistical methods) | ☐ | |
| | 13d | Describe methods for exploring causes of heterogeneity | ☐ | |
| | 13e | Describe sensitivity analyses | ☐ | |
| Reporting bias | 14 | Describe methods for assessing publication bias | ☐ | |
| Certainty assessment | 15 | Describe methods for assessing certainty of evidence | ☐ | |
| **RESULTS** | | | | |
| Study selection | 16a | Describe results of search and selection (with flow diagram) | ☐ | |
| | 16b | Cite excluded studies and reasons | ☐ | |
| Study characteristics | 17 | Cite each study and present characteristics | ☐ | |
| Risk of bias | 18 | Present assessments of risk of bias | ☐ | |
| Results synthesis | 19a | Present results for all outcomes (with confidence intervals) | ☐ | |
| | 19b | Present results of meta-analyses (forest plots) | ☐ | |
| Reporting biases | 20 | Present assessment of publication bias | ☐ | |
| Certainty | 21 | Present certainty of evidence assessments | ☐ | |
| **DISCUSSION** | | | | |
| Discussion | 22a | Provide general interpretation in context of other evidence | ☐ | |
| | 22b | Discuss limitations | ☐ | |
| | 22c | Discuss implications for practice, policy, and research | ☐ | |
| **OTHER** | | | | |
| Registration | 23a | Provide registration info including number | ☐ | |
| | 23b | Indicate where protocol can be accessed | ☐ | |
| | 23c | Describe and explain deviations from protocol | ☐ | |
| Support | 24 | Describe sources of financial/non-financial support | ☐ | |
| Competing interests | 25 | Declare competing interests | ☐ | |
| Data availability | 26 | Report which data are publicly available and where | ☐ | |
| Code availability | 27 | Report which analysis code is available and where | ☐ | |

### Review Writing Timeline

```
Week 1-2: Results Section
├─ Create all tables and figures
├─ Write study selection results
├─ Describe study characteristics
├─ Present quality assessment
└─ Report synthesis results

Week 3-4: Methods Section
├─ Document protocol details
├─ Describe search strategy
├─ Explain selection process
├─ Detail data extraction
└─ Describe analysis methods

Week 5: Introduction & Abstract
├─ Write background and rationale
├─ State objectives clearly
├─ Draft structured abstract
└─ Finalize title

Week 6-7: Discussion & Conclusion
├─ Interpret findings
├─ Discuss in context of existing evidence
├─ Address limitations honestly
├─ State implications
└─ Draw evidence-based conclusions

Week 8: Finalization
├─ Check PRISMA compliance
├─ Format references
├─ Proofread thoroughly
├─ Prepare supplementary materials
└─ Submit to co-authors for review
```

### Essential Tables and Figures

| Table/Figure | Purpose | Contents |
|--------------|---------|----------|
| **PRISMA Flow Diagram** | Show study selection process | Numbers at each stage, exclusion reasons |
| **Table 1: Study Characteristics** | Describe included studies | Author, year, design, setting, sample size, intervention details |
| **Table 2: Risk of Bias Summary** | Present quality assessment | Judgments for each domain per study |
| **Table 3: Summary of Findings** | Present key results | Outcomes, effect estimates, certainty ratings |
| **Forest Plot(s)** | Show meta-analysis results | Individual study effects, pooled estimate, heterogeneity |
| **Funnel Plot** | Assess publication bias | Visual asymmetry check |

## Step 12: Dissemination and Updates

### Publication Strategy

| Target | Format | Timeline | Audience |
|--------|--------|----------|----------|
| **Peer-reviewed journal** | Full manuscript | Months 18-24 | Academic/clinical |
| **Conference presentation** | Abstract + slides/poster | Months 12-18 | Academic/clinical |
| **Policy brief** | 2-4 page summary | Month 24+ | Policymakers |
| **Plain language summary** | 1-page infographic | Month 24+ | General public |
| **Blog post/social media** | 500-1000 words | Month 24+ | Broader audience |
| **Webinar/workshop** | Interactive presentation | Month 24+ | Stakeholders |

### Target Journal Selection Criteria

| Criterion | Considerations |
|-----------|----------------|
| **Scope** | Does journal publish systematic reviews in your topic area? |
| **Impact** | Journal impact factor and citation metrics |
| **Audience** | Who reads the journal? |
| **Open Access** | Required by funder? Cost? |
| **Turnaround Time** | How quickly do they typically review and publish? |
| **Requirements** | Word limits, structure requirements, supplement policies |

### Data and Materials Sharing

| Item | Where to Share | Purpose |
|------|----------------|---------|
| **Protocol** | PROSPERO, OSF, journal supplement | Transparency, replication |
| **Search strategies** | Journal supplement | Replication |
| **PRISMA checklist** | Journal supplement | Reporting completeness |
| **Data extraction forms** | OSF, Figshare | Replication |
| **Extracted data** | OSF, Figshare, Dryad | Replication, secondary analysis |
| **Risk of bias assessments** | Journal supplement or OSF | Transparency |
| **Analysis code** | GitHub, OSF | Reproducibility |
| **Supplementary analyses** | Journal supplement | Complete reporting |

### Update Planning

```
┌─────────────────────────────────────────────────────────────┐
│             SYSTEMATIC REVIEW UPDATE CYCLE                  │
└─────────────────────────────────────────────────────────────┘

INITIAL REVIEW PUBLISHED
         │
         ▼
SURVEILLANCE (Ongoing)
├─ Set up alerts for new studies
├─ Monitor key journals
├─ Check trial registries
└─ Track citations to review
         │
         ▼
ASSESSMENT (Every 6-12 months)
├─ How many new studies identified?
├─ Do new studies change conclusions?
├─ Have methods/guidelines changed?
└─ Is update warranted?
         │
         ▼
DECISION POINT
├─ No update needed → Continue surveillance
├─ Minor update → Publish brief update/letter
└─ Major update → Full systematic review update
         │
         ▼
UPDATE REVIEW (If warranted)
├─ Update search (same strategy)
├─ Screen and select new studies
├─ Extract data from new studies
├─ Re-assess all included studies with current tools
├─ Re-synthesize all data
└─ Publish updated review
         │
         ▼
REPEAT CYCLE
```

### Criteria for Update Decision

| Trigger | Action |
|---------|--------|
| **5+ new studies meeting inclusion criteria** | Consider update |
| **New study contradicts main findings** | Priority update |
| **Substantial change in clinical practice** | Update needed |
| **New/improved methodology available** | Consider update |
| **3-5 years since publication** | Routine update assessment |
| **Request from stakeholders** | Evaluate need |

## Common Challenges and Solutions

### Challenge Summary Table

| Challenge | Potential Solutions | Prevention Strategies |
|-----------|-------------------|----------------------|
| **Too many results (>10,000)** | • Narrow PICO<br>• Add date limits<br>• Focus on specific populations<br>• Add study design filters | • Pilot test search strategy<br>• Consult librarian<br>• Define focused question |
| **Too few results (<5)** | • Broaden inclusion criteria<br>• Include more study designs<br>• Extend date range<br>• Search more databases | • Preliminary scoping<br>• Literature familiarity check<br>• Consult experts |
| **High heterogeneity (I²>75%)** | • Narrative synthesis instead<br>• Explore with subgroups<br>• Meta-regression<br>• Discuss as finding | • Clear eligibility criteria<br>• Pilot with similar studies<br>• Plan subgroup analyses |
| **Missing data** | • Contact authors<br>• Use imputation<br>• Sensitivity analyses<br>• Note limitations | • Design comprehensive extraction form<br>• Plan for missing data |
| **Poor study quality** | • Sensitivity analysis by quality<br>• Downgrade GRADE rating<br>• Discuss impact | • Include quality criteria<br>• Plan quality assessment |
| **Publication bias detected** | • Trim-and-fill analysis<br>• Search gray literature<br>• Discuss impact<br>• Interpret cautiously | • Comprehensive search<br>• Gray literature inclusion<br>• Trial registry searches |
| **Disagreements between reviewers** | • Third reviewer arbitration<br>• Team discussion<br>• Revise criteria<br>• Additional training | • Clear protocols<br>• Pilot screening<br>• Regular team meetings |
| **Time/resource constraints** | • Prioritize critical steps<br>• Focus review scope<br>• Seek additional support<br>• Consider rapid review | • Realistic timeline<br>• Adequate team size<br>• Early resource planning |

## Resource Requirements

### Personnel and Time Estimates

| Task | Personnel | Time Estimate |
|------|-----------|---------------|
| **Protocol development** | Lead + 1-2 co-investigators | 2-4 weeks |
| **Search strategy** | Lead + librarian | 1-2 weeks |
| **Database searching** | 1 reviewer | 1 week |
| **Title/abstract screening** | 2 independent reviewers | 2-6 weeks |
| **Full-text review** | 2 independent reviewers | 2-4 weeks |
| **Data extraction** | 2 independent reviewers | 4-8 weeks |
| **Quality assessment** | 2 independent reviewers | 2-4 weeks |
| **Data synthesis** | Lead + statistician | 4-6 weeks |
| **Manuscript writing** | Lead + co-authors | 6-8 weeks |
| **Revisions** | All authors | 2-4 weeks |
| **Total** | Team of 3-5 | **6-18 months** |

### Software and Tools

| Purpose | Free Options | Paid Options | Cost Range |
|---------|--------------|--------------|------------|
| **Reference Management** | Zotero, Mendeley | EndNote, RefWorks | $0-250/year |
| **Screening** | Rayyan, Covidence (free trial) | Covidence, DistillerSR | $0-5,000/project |
| **Data Extraction** | Microsoft Excel, Google Sheets | Covidence, DistillerSR | $0-5,000 |
| **Quality Assessment** | RevMan (Cochrane) | Covidence | Free-$5,000 |
| **Meta-Analysis** | RevMan, R (meta package), OpenMeta[Analyst] | Stata, Comprehensive Meta-Analysis | $0-1,500 |
| **GRADE Assessment** | GRADEpro GDT | GRADEpro GDT (full version) | Free-$200 |
| **Diagram Creation** | Microsoft PowerPoint, Google Slides | Adobe Illustrator, Lucidchart | $0-50/month |

## Conclusion

Conducting a systematic literature review is a rigorous, time-intensive process
that requires careful planning, meticulous execution, and transparent
reporting. By following these 12 detailed steps, you can produce a high-quality
review that:

- **Minimizes bias** through systematic, reproducible methods
- **Synthesizes evidence** comprehensively and objectively  
- **Informs practice** with reliable, trustworthy conclusions
- **Guides future research** by identifying knowledge gaps
- **Influences policy** with robust evidence summaries

### Key Success Factors

1. **Well-formulated question** using appropriate framework (PICO, PEO, etc.)
2. **Detailed protocol** registered before starting
3. **Comprehensive search** across multiple sources
4. **Independent screening** by multiple reviewers
5. **Systematic data extraction** with pilot testing
6. **Rigorous quality assessment** using validated tools
7. **Appropriate synthesis** matching data characteristics
8. **Transparent reporting** following PRISMA guidelines
9. **Honest limitation** acknowledgment
10. **Plan for updates** to maintain relevance

### Final Checklist

✓ Research question clearly defined 

✓ Protocol developed and registered

✓ Search strategy comprehensive and documented

✓ Study selection transparent with PRISMA diagram

✓ Data extraction systematic and verified

✓ Quality assessment rigorous and independent

✓ Synthesis appropriate for data

✓ GRADE certainty assessment completed

✓ PRISMA checklist completed

✓ All materials available for transparency

✓ Limitations discussed honestly

✓ Conclusions supported by evidence

✓ Update plan established

The systematic review methodology represents the highest level of evidence
synthesis. While demanding in terms of time and resources, the investment
produces trustworthy evidence that advances knowledge, informs decision-making,
and ultimately improves outcomes in your field.

Remember: **Transparency, rigor, and reproducibility** are the cornerstones of
systematic review methodology. Document every decision, maintain objectivity
throughout, and let the evidence guide your conclusions.

## References

1. <a name="ref1"></a> **Monash University.** *Structuring a literature review.* https://www.monash.edu/student-academic-success/excel-at-writing/how-to-write/literature-review/structuring-a-literature-review  
2. <a name="ref2"></a> **QUT Cite|Write.** *Writing a literature review.* https://www.citewrite.qut.edu.au/write/writing-well/litreview.html  
3. <a name="ref3"></a> **University of Melbourne.** *Writing a literature review.* https://students.unimelb.edu.au/academic-skills/resources/reading,-writing-and-referencing/literature-reviews/writing-a-lit-review  
4. <a name="ref4"></a> **USC Graduate Writing Coach.** *Introductions vs. literature reviews.* https://sites.usc.edu/graduate-writing-coach/introductions-vs-and-literature-reviews  
5. <a name="ref5"></a> **Australian National University.** *Placement of the traditional literature review.* https://www.anu.edu.au/students/academic-skills/research-writing/literature-reviews/placement-of-traditional-literature  
6. <a name="ref6"></a> **University of Queensland Library.** *Literature reviews: Tools and techniques.* https://guides.library.uq.edu.au/tools-and-techniques/literature-reviews  
7. <a name="ref7"></a> **UTS HELPS.** *Literature reviews.* https://www.uts.edu.au/for-students/current-students/support/helps/self-help-resources/types-assignments/literature-reviews  
8. <a name="ref8"></a> **Curtin University Library.** *Introduction to literature reviews.* https://researchtoolkit.library.curtin.edu.au/searching/literature-reviews/introduction  
9. <a name="ref9"></a> **Charles Darwin University.** *Writing a literature review.* https://www.cdu.edu.au/library/language-and-learning-support/study-skills/research-communication/writing-literature-review  
10. <a name="ref10"></a> **UNSW Sydney Library.** *Literature reviews.* https://subjectguides.library.unsw.edu.au/literature-reviews  
11. <a name="ref11"></a> **University of Wollongong.** *Literature review.* https://www.uow.edu.au/student/support-services/academic-skills/online-resources/assessments/literature-review  
13. <a name="ref13"></a> **NCBI Bookshelf.** *A How-to Guide for Conducting a Systematic Review.* https://www.ncbi.nlm.nih.gov/books/NBK481583  
14. <a name="ref14"></a> **University of Reading Library.** *Getting started with your literature review.* https://libguides.reading.ac.uk/literaturereview/starting  
15. <a name="ref15"></a> **University of Canberra Library.** *Literature reviews.* https://canberra.libguides.com/c.php?g=940615  
16. <a name="ref16"></a> **University of Edinburgh.** *Literature review.* https://institute-academic-development.ed.ac.uk/study-hub/learning-resources/literature-review  
17. <a name="ref17"></a> **Snyder, H. (2019).** *Literature review as a research methodology.* Journal of Business Research, 104, 333–339.  
18. <a name="ref18"></a> **Paul, J., & Criado, A. R. (2020).** *The art of writing literature review.* International Business Review, 29(4), 101717.  
19. <a name="ref19"></a> **Tranfield, D., et al. (2003).** *Towards a methodology for evidence-informed management.* British Journal of Management, 14(3), 207–222.  
20. <a name="ref20"></a> **Webster, J., & Watson, R. T. (2002).** *Analyzing the past to prepare for the future.* MIS Quarterly, xiii–xxiii.  
21. <a name="ref21"></a> **Donthu, N., et al. (2021).** *How to conduct a bibliometric analysis.* Journal of Business Research, 133, 285–296.  
22. <a name="ref22"></a> **Whittemore, R., & Knafl, K. (2005).** *The integrative review: updated methodology.* Journal of Advanced Nursing, 52(5), 546–553.  
23. <a name="ref23"></a> **Booth, A., et al. (2021).** *Systematic approaches to a successful literature review.* Sage.

[^1]: https://www.monash.edu/student-academic-success/excel-at-writing/how-to-write/literature-review/structuring-a-literature-review

[^2]: https://www.citewrite.qut.edu.au/write/writing-well/litreview.html

[^3]: https://students.unimelb.edu.au/academic-skills/resources/reading,-writing-and-referencing/literature-reviews/writing-a-lit-review

[^4]: https://sites.usc.edu/graduate-writing-coach/introductions-vs-and-literature-reviews

[^5]: https://www.anu.edu.au/students/academic-skills/research-writing/literature-reviews/placement-of-traditional-literature

[^6]: https://guides.library.uq.edu.au/tools-and-techniques/literature-reviews

[^7]: https://www.uts.edu.au/for-students/current-students/support/helps/self-help-resources/types-assignments/literature-reviews

[^8]: https://researchtoolkit.library.curtin.edu.au/searching/literature-reviews/introduction

[^9]: https://www.cdu.edu.au/library/language-and-learning-support/study-skills/research-communication/writing-literature-review

[^10]: https://subjectguides.library.unsw.edu.au/literature-reviews

[^11]: https://www.uow.edu.au/student/support-services/academic-skills/online-resources/assessments/literature-review

[^12]: https://owl.purdue.edu/owl/research_and_citation/conducting_research/writing_a_literature_review.html

[^13]: https://www.ncbi.nlm.nih.gov/books/NBK481583

[^14]: https://libguides.reading.ac.uk/literaturereview/starting

[^15]: https://canberra.libguides.com/c.php?g=940615

[^16]: https://institute-academic-development.ed.ac.uk/study-hub/learning-resources/literature-review

[^17]: Snyder, Hannah. "Literature review as a research methodology: An overview and guidelines." Journal of business research 104 (2019): 333-339.

[^18]: Paul, Justin, and Alex Rialp Criado. "The art of writing literature review: what do we know and what do we need to know?." International business review 29.4 (2020): 101717.

[^19]: Tranfield, David, David Denyer, and Palminder Smart. "Towards a methodology for developing evidence‐informed management knowledge by means of systematic review." British journal of management 14.3 (2003): 207-222.

[^20]: Webster, Jane, and Richard T. Watson. "Analyzing the past to prepare for the future: Writing a literature review." MIS quarterly (2002): xiii-xxiii.

[^21]: Donthu, Naveen, et al. "How to conduct a bibliometric analysis: An overview and guidelines." Journal of business research 133 (2021): 285-296.

[^22]: Whittemore, Robin, and Kathleen Knafl. "The integrative review: updated methodology." Journal of advanced nursing 52.5 (2005): 546-553.

[^23]: Booth, Andrew, et al. "Systematic approaches to a successful literature review." (2021): 1-100.
